Skip to main content

Peer Review reports

From: PPIs therapy has a negative impact on the clinical outcomes of advanced SCLC patients treated with PD-L1 inhibitors

Original Submission
7 May 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Sep 2023 Reviewed Reviewer Report
5 Oct 2023 Reviewed Reviewer Report - Francesco Facchinetti
13 Oct 2023 Reviewed Reviewer Report
13 Oct 2023 Reviewed Reviewer Report
31 Oct 2023 Author responded Author comments - Chengxin Liu
Resubmission - Version 4
31 Oct 2023 Submitted Manuscript version 4
1 Nov 2023 Author responded Author comments - Chengxin Liu
Resubmission - Version 5
1 Nov 2023 Submitted Manuscript version 5
2 Nov 2023 Author responded Author comments - Chengxin Liu
Resubmission - Version 6
2 Nov 2023 Submitted Manuscript version 6
2 Nov 2023 Reviewed Reviewer Report - Francesco Facchinetti
4 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
7 Nov 2023 Editorially accepted
11 Nov 2023 Article published 10.1186/s12890-023-02754-4

You can find further information about peer review here.

Back to article page